STRO
Sutro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Best Biotech Stocks 2026 →
Sutro Biopharma (STRO) Stock: Buy, Sell, or Hold?
$10.10
-0.07 (-0.74%)
âŧ
5d:
+1.56%
30d:
-8.31%
90d:
-52.63%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
40/100
Position
FAIR
30-Day Fair Range
$8.98 â $13.01
Position: FAIR
Forward P/E & Valuation
-1.7x
Next 12M consensus est.
Wall Street Target
$47.23
+364.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$8.80 / $10.77
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: STRO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When STRO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: STRO is currently trading at $10.10, which is considered fair relative to its 30-day fair value range of $8.98 to $13.01.
Technical Outlook: Technically, STRO is in a strong downtrend. Immediate support is located at $8.80, while resistance sits at $10.77.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $47.23 (+364.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, STRO is in a strong downtrend. Immediate support is located at $8.80, while resistance sits at $10.77.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $47.23 (+364.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$8.98 -
$13.01
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
74.7%
Trading Range & Key Levels
30-Day Trading Range
$8.98 -
$13.01
Current vs Trading Range
FAIR
Support Level
$8.80
Resistance Level
$10.77
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 364.4% below Wall St target ($47.23)
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.67
Wall Street Target
$47.23
(+364.4%)
Revenue Growth (YoY)
-84.6%
Share STRO Analysis
Share this live STRO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (STRO)
Bullish
2 Retail Mentions
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Aug 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Sutro Biopharma reported encouraging early clinical activity and rapid progress in its Phase 1 study of STRO-004, with the second dual-payload iADC program from its collaboration with Astellas expected to enter the clinic in H2 2026.
Key Retail Themes:
Encouraging early clinical activity of STRO-004
Progress in the development of next-generation ADCs
Astellas collaboration
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 12:21 PM ET
Data refreshes hourly during market hours. Next update: 1:21 PM
Data refreshes hourly during market hours. Next update: 1:21 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STRO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 43 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive STRO Research Pages
